At Rusan Pharma Ltd., we are driven by a singular purpose: to help individuals overcome addiction and manage pain through innovative, world-class pharmaceutical solutions. Since our inception in 1994, we have specialised in providing treatments that address some of the most pressing health challenges—addiction and pain management.
Headquartered in India, we are a fully integrated, global pharmaceutical company, utilizing cutting-edge technology to deliver the best-in-class products that make a real difference in people’s lives.
In 2014, Rusan Pharma introduced 2baconil, India’s first Nicotine Transdermal Patch and Nicotine Gum, revolutionizing tobacco addiction treatment. Today, 2baconil is the most recommended nicotine patch by healthcare professionals across India, helping thousands take the courageous step towards quitting tobacco.
Our dedication to innovation and patient care is backed by the countless success stories of those who have benefitted from our nicotine replacement therapies.
Leaders, Innovators, Supporters, In De-Addiction Medications
Our Vision
To bring advanced, technology-driven treatments for neglected diseases, ensuring the best care and products for our consumers.
Our Mission
To provide affordable, world-class medicines globally, working towards a healthier, happier world- because, access to quality healthcare is a right, not a privilege.
Superior Performance: Our Core Values
Rusan's core foundation is rooted in superior performance, consistently meeting current challenges and demands by providing relevant, high-quality medicines. We prioritise innovation and adaptability, ensuring our products effectively address the ever-evolving needs of healthcare- thus making a difference in the lives of our consumers.
Global Reach and Impact
Rusan Pharma has a global footprint, offering a complete range of de-addiction and pain management products across key markets including Europe, the UK, Russia, the CIS, South Africa, Mauritius, Nepal, and Myanmar. We are proud to be one of the largest suppliers of life-saving drugs to organisations like NACO, UNODC, UNOPS, and the Global Fund, along with various Ministries of Health in emerging markets. Since 1994, we have been pioneers in promoting Opioid Substitution Treatment (OST) in India. Our work continues to shape policies, educate healthcare providers, and ensure widespread access to this critical treatment.
